TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1 - Cardellini, Marina; Menghini, Rossella; Martelli, Eugenio; Casagrande, Viviana; Marino, Arianna; Rizza, Stefano; Porzio, Ottavia; Mauriello, Alessandro; Solini, Anna; Ippoliti, Arnaldo; Lauro, Renato; Folli, Franco; et al. (Diabetes (New York, N.Y.), 2009)
Keywords: ADAM Proteins - genetics; ADAM Proteins - metabolism; ADAM17 Protein; Animals; Antibodies; Atherosclerosis; Atherosclerosis (general aspects, experimental research); Atherosclerosis - metabolism; Atherosclerosis - pathology; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Care and treatment; Carotid Arteries - metabolism; Carotid Artery Diseases - metabolism; Cell culture; Complications and side effects; Diabetes; Diabetes Mellitus, Type 2 - metabolism; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Gene expression; Genetic aspects; Glucose; Health aspects; Humans; Insulin resistance; Matrix Metalloproteinase 9 - genetics; Matrix Metalloproteinase 9 - metabolism; Matrix metalloproteinase inhibitors; Medical sciences; Metabolism; Mice; Original; Reference Values; Research design; Reverse Transcriptase Polymerase Chain Reaction; Risk factors; Sirtuin 1; Sirtuins - metabolism; Smooth muscle; Statistical analysis; Tissue Inhibitor of Metalloproteinase-3 - metabolism; Type 2 diabetes; United States; Endocrinopathy; Vascular disease; Type 2 diabetes; Human; Atherosclerotic plaque; Atherosclerosis; Metabolic diseases; Cardiovascular disease